| CENTAIX Celularity Inc.
97260922 10 Feb 2022 | on 17 Jul 2023 | lowable and particulate material, namely, human placental biological c... Class 005 Class 005 Pharmaceutical Products CENTA IX | | | CYCART Celularity Inc.
90765924 10 Jun 2021 | on 15 Jun 2023 | Bioengineered cells for use in scientific, laboratory and medical rese... Class 001 Class 001 Chemical Products Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, placental-derived cells, umbilical cord cells, placental-derived T cells, chimeric antigen receptor (CAR) T cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; biological tissue intended for use as a wound covering and burn dressing; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds and burns; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen Class 005 Class 005 Pharmaceutical Products Bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; placental-derived cells, chimeric antigen receptor (CAR) T cells, and placental-derived T cells with a chimeric antigen receptor (CAR), all for use in scientific, laboratory and medical research | | | AESTHETIC REGENERATIVE THERAPY (A.R.T.) Celularity, Inc.
88082248 17 Aug 2018 | on 25 Jul 2022 | Medical and cosmeceutical treatment using cells and biological tissue,... Class 044 Class 044 Medical, Beauty & Agricultural Services "AESTHETIC REGENERATIVE THERAPY" | | | AUGMENTE VITALITY Celularity Inc.
87863112 04 Apr 2018 | on 25 Apr 2022 | Cells and biological preparations intended for medical and clinical us... Class 005 Class 005 Pharmaceutical Products Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's isease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease associated antigen | | | AUGMENTE IMMUNITY Celularity Inc.
87863059 04 Apr 2018 | on 25 Apr 2022 | Cells and biological preparations intended for medical and clinical us... Class 005 Class 005 Pharmaceutical Products "IMMUNITY" | | | AUGMENTE LONGEVITY Celularity Inc.
87863040 04 Apr 2018 | on 25 Apr 2022 | Cells and biological preparations intended for medical and clinical us... Class 005 Class 005 Pharmaceutical Products Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's isease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease associated antigen | | | CENTAFIX Celularity Inc.
88062553 02 Aug 2018 | on 08 Mar 2022 | Flowable and particulate material, namely, human placental biological ... Class 005 Class 005 Pharmaceutical Products Flowable and particulate material, namely, human placental biological connective tissue for the replacement or supplementation of damaged or inadequate integumental tissue | | | CENTAPLAST Celularity Inc.
88062653 02 Aug 2018 | on 08 Mar 2022 | Biological tissue for use as a wound covering; wound dressings; burn d... Class 005 Class 005 Pharmaceutical Products Biological tissue for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds | | | UNIVERSAL PINK CAR Celularity Inc.
87863129 04 Apr 2018 | on 10 Jan 2022 | Biological preparations for medical purposes for the treatment of canc... Class 005 Class 005 Pharmaceutical Products "CAR" | | | CC CELULARITY Celularity, Inc.
88641502 03 Oct 2019 | on 31 May 2021 | Cells and biological preparations intended for medical and clinical us... Class 001 Class 001 Chemical Products The mark consists of two "CC's" intersecting in the middle with the tips of the "C's" in teal blending to blue as moving toward the center of the "C's" blending to purple as continue to move toward the middle of the "C's" and intersecting at lilac and then blending back to purple and then blue and then to teal as proceed to other end of the "C's", and to the left of the intersection of the "C's" is the word "CELULARITY" in grey. Class 005 Class 005 Pharmaceutical Products The color(s) teal, blue, purple, lilac and grey is/are claimed as a feature of the mark. Class 042 Computer & Software Services & Scientific Services The mark consists of two "CC's" intersecting in the middle with the tips of the "C's" in teal blending to blue as moving toward the center of the "C's" blending to purple as continue to move toward the middle of the "C's" and intersecting at lilac and then blending back to purple and then blue and then to teal as proceed to other end of the "C's", and to the left of the intersection of the "C's" is the word "CELULARITY" in grey. | | 
